Romosozumab versus Teriparatide for the Treatment of Postmenopausal Osteoporosis: A Systematic Review and Meta‐analysis through a Grade Analysis of Evidence-Reference-Cited by-同舟云学术

Romosozumab versus Teriparatide for the Treatment of Postmenopausal Osteoporosis: A Systematic Review and Meta‐analysis through a Grade Analysis of Evidence

Published:2021-10 Issue:7 Volume:13 Page:1941-1950
ISSN:1757-7853
Container-title:Orthopaedic Surgery
language:en
Short-container-title:Orthop Surg

Author:

Tian Aixian¹,Jia Haobo²³,Zhu Shan⁴,Lu Bin¹,Li Yan¹,Ma Jianxiong¹,Ma Xinlong¹³^ORCID

Affiliation:

1. Orthopedic Research Institute, Tianjin Hospital Heping Branch Tianjin University Tianjin China

2. Tianjin Medical University Tianjin China

3. Orthopaedics Institute, Tianjin Hospital Tianjin University Tianjin China

4. Department of Radiology, Tianjin Hospital Tianjin University Tianjin China

Funder

Natural Science Foundation of Tianjin City

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Surgery

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/os.13136

Reference45 articles.

1. Osteoporosis

2. More DATA to guide sequential osteoporosis therapy

3. Osteoporosis: now and the future

4. Romosozumab in Postmenopausal Women with Low Bone Mineral Density

5. Long-Term Use of Bisphosphonates in Osteoporosis

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug utilization pattern of romosozumab and other osteoporosis treatments in Japan, 2019–2021;Journal of Bone and Mineral Metabolism;2024-07-10

2. Efficacy and safety of romosozumab: a meta-analysis of placebo-controlled trials;Journal of Bone and Mineral Metabolism;2024-07-08

3. Bone protective effects of the polysaccharides from Grifola frondosa on ovariectomy-induced osteoporosis in mice via inhibiting PINK1/Parkin signaling, oxidative stress and inflammation;International Journal of Biological Macromolecules;2024-06

4. RNA sequencing-based approaches to identifying disulfidptosis-related diagnostic clusters and immune landscapes in osteoporosis;Aging;2024-05-10

5. Cardiovascular Safety of Romosozumab vs PTH Analogues for Osteoporosis Treatment: A Propensity-Score-Matched Cohort Study;The Journal of Clinical Endocrinology & Metabolism;2024-03-14